Test Price
4,800 AED✅ Home Collection Available
Lung Cancer Panel 7 (EGFR, BRAF, ALK1, ROS1, MET) – Genomic Profiling for Non-Small Cell Lung Cancer
Executive Summary & Core Metrics
DNA Labs UAE offers a comprehensive genomic profiling panel for non‑small cell lung cancer (NSCLC), detecting key driver mutations and gene rearrangements in EGFR, BRAF, ALK1, ROS1, and MET using next‑generation sequencing (NGS) and fluorescence in situ hybridization (FISH). This panel provides a diagnostic sensitivity of 99.9% and is accredited under ISO 9001:2015, guiding precise targeted therapy selection.
- Price: 4,800 AED
- Turnaround Time: 5–7 business days
- Sample: Tumor tissue biopsy (hospital extraction only)
- Methodology: NGS + FISH, ISO 9001:2015
- DHA Facility License No.: 1143
- Lab Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Test Overview & Methodology
This panel simultaneously analyzes seven critical genomic targets in NSCLC. The combined use of NGS (for point mutations and indels) and FISH (for translocations and copy number alterations) enables comprehensive detection of actionable alterations, including EGFR exon 19 deletions, L858R, T790M, BRAF V600E, ALK rearrangements, ROS1 fusions, and MET amplification or exon 14 skipping mutations.
| Feature | Our Panel | Closest Alternative |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity via NGS & FISH | Single‑gene PCR; lower sensitivity for rare variants |
| Method | NGS + FISH (ISO‑accredited) | Conventional Sanger sequencing; limited fusion detection |
| Turnaround Time | 5–7 days | 7–10 days |
Physician Insight & Safety Protocols
“Genomic profiling of lung cancer is a pivotal decision‑making tool that can reveal life‑extending targeted therapies. I urge every patient to review these results jointly with their treating oncologist, as clinical context is essential to translating molecular findings into a personalised care plan.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Notice
Do not alter or discontinue any prescribed medications without prior consultation with your treating physician. The results of this test are complementary and do not replace clinical judgement or routine medical care.
Exclusion Criteria & Emergency Red Flags
- This test requires a tumor tissue biopsy obtained by an accredited hospital; liquid biopsy alternatives are not covered without prior physician approval.
- Not intended for asymptomatic screening – only for patients with confirmed or strongly suspected NSCLC.
- Emergency red flags after biopsy: severe pain, bleeding, fever, or signs of infection – seek immediate medical attention.
- Minors require parental consent in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. How accurate is this lung cancer panel for selecting targeted therapy?
Our panel achieves 99.9% diagnostic sensitivity using NGS and FISH, directly matching actionable mutations to approved targeted drugs.
2. What sample is required and how is it collected?
A tumour tissue biopsy is required. Collection is performed strictly within an accredited hospital facility; mobile home phlebotomy is not available for this test.
3. Will my insurance cover this test?
We offer direct billing verification via WhatsApp at +971 54 548 8731. Many UAE insurers reimburse guideline‑based genomic testing for NSCLC.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient genomic data is encrypted, access‑restricted, and processed in compliance with UAE health data sovereignty requirements.
Clinical & Logistical Metadata
| Test Name | Lung Cancer Panel 7 (EGFR, BRAF, ALK1, ROS1, MET) – Genomic Profiling |
| Price (AED) | 4,800 |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | Tumor tissue biopsy (formalin‑fixed paraffin‑embedded block or unstained slides) |
| Methodology Used | Next‑Generation Sequencing (NGS) + Fluorescence In Situ Hybridization (FISH) |
| ICD-10-CM Code | C34.90 |
| LOINC Code | 92874-8 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians